What Parents Should Know About Pfizer COVID-19 Vaccine for Kids Under 12

Pfizer recently announced encouraging results from a clinical trial of children ages 5 to 11. The drugmaker gave children a smaller dose to find they developed a robust antibody response.

No comments:

Post a Comment